首页 > 最新文献

Phenomics (Cham, Switzerland)最新文献

英文 中文
Embracing Interpersonal Variability of Microbiome in Precision Medicine. 在精准医学中拥抱微生物组的人际变异。
IF 3.7 Q2 GENETICS & HEREDITY Pub Date : 2025-02-19 eCollection Date: 2025-02-01 DOI: 10.1007/s43657-024-00201-w
Xin Zhou, Xin Chen, Mark M Davis, Michael P Snyder
{"title":"Embracing Interpersonal Variability of Microbiome in Precision Medicine.","authors":"Xin Zhou, Xin Chen, Mark M Davis, Michael P Snyder","doi":"10.1007/s43657-024-00201-w","DOIUrl":"10.1007/s43657-024-00201-w","url":null,"abstract":"","PeriodicalId":74435,"journal":{"name":"Phenomics (Cham, Switzerland)","volume":"5 1","pages":"8-13"},"PeriodicalIF":3.7,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12040794/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144048080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differences in Pathogenetic Mechanism Between Tibetan and Han High-Altitude Polycythemia Based on a Whole Genome-Wide Association Study. 基于全基因组关联研究的青藏高原红细胞增多症发病机制差异
IF 3.7 Q2 GENETICS & HEREDITY Pub Date : 2025-02-15 eCollection Date: 2025-04-01 DOI: 10.1007/s43657-024-00180-y
Zhuoma Basang, Shixuan Zhang, Xianwei Ke, Zhuoma Duoji, La Yang, Danzeng Qiangba, Yang De, Deji Gesang, Zixin Hu, Yanyun Ma, Meng Hao, Ruidong Fan, Li Han, Zeshan Lin, Yi Li, Jiucun Wang, Juan Wu

High-altitude polycythemia (HAPC) is a prevalent chronic condition affecting individuals at high altitudes, including both highland and plains populations. This study, involving 2248 participants, explored genetic susceptibility to HAPC among ethnic groups, with 898 HAPC patients (450 Han, 448 Tibetan). The Genome-wide Association Study, encompassing 198 cases (100 Han, 98 Tibetan), identified eight Tibetan HAPC-susceptibility single-nucleotide polymorphisms and four in Han individuals. The common polymorphism locus rs7618658 (SNX4, p combine < 5 × 10-8) was validated in both populations. The investigation of Tibetan EPAS1 revealed the rs1374749 locus, along with linked loci, as a potential prevalence factor for HAPC. The GGTAC haplotype containing this locus emerged as a Protect haplotype for HAPC (p = 2.461 × 10-12, OR = 0.344). Enrichment analysis revealed that Tibetans exhibited susceptibility in oxygen-sensing pathways, such as EPAS1, associated with phenotypes like hemoglobin and platelets. In contrast, Han Chinese showed significant sensitivity in cell differentiation and angiogenesis, closely linked to hemoglobin, hematocrit, and platelets.

Supplementary information: The online version contains supplementary material available at 10.1007/s43657-024-00180-y.

高原红细胞增多症(HAPC)是一种影响高海拔地区个体的普遍慢性疾病,包括高原和平原人群。本研究共纳入2248名受试者,共纳入898例HAPC患者(汉族450例,藏族448例),探讨不同民族间HAPC的遗传易感性。该全基因组关联研究涵盖了198例(汉族100例,藏族98例),鉴定出8个藏族hapc易感性单核苷酸多态性和4个汉族个体hapc易感性单核苷酸多态性。共同多态性位点rs7618658 (SNX4, p combine -8)在两个群体中得到验证。藏族EPAS1基因的调查显示,rs1374749位点及其连锁位点可能是HAPC的潜在流行因子。含有该位点的GGTAC单倍型成为HAPC的保护单倍型(p = 2.461 × 10-12, OR = 0.344)。富集分析显示,西藏人在与血红蛋白和血小板等表型相关的氧感应通路(如EPAS1)中表现出敏感性。相比之下,汉族在细胞分化和血管生成方面表现出显著的敏感性,与血红蛋白、红细胞压积和血小板密切相关。补充信息:在线版本包含补充资料,下载地址:10.1007/s43657-024-00180-y。
{"title":"Differences in Pathogenetic Mechanism Between Tibetan and Han High-Altitude Polycythemia Based on a Whole Genome-Wide Association Study.","authors":"Zhuoma Basang, Shixuan Zhang, Xianwei Ke, Zhuoma Duoji, La Yang, Danzeng Qiangba, Yang De, Deji Gesang, Zixin Hu, Yanyun Ma, Meng Hao, Ruidong Fan, Li Han, Zeshan Lin, Yi Li, Jiucun Wang, Juan Wu","doi":"10.1007/s43657-024-00180-y","DOIUrl":"10.1007/s43657-024-00180-y","url":null,"abstract":"<p><p>High-altitude polycythemia (HAPC) is a prevalent chronic condition affecting individuals at high altitudes, including both highland and plains populations. This study, involving 2248 participants, explored genetic susceptibility to HAPC among ethnic groups, with 898 HAPC patients (450 Han, 448 Tibetan). The Genome-wide Association Study, encompassing 198 cases (100 Han, 98 Tibetan), identified eight Tibetan HAPC-susceptibility single-nucleotide polymorphisms and four in Han individuals. The common polymorphism locus rs7618658 (<i>SNX4</i>, <i>p</i> <sub>combine</sub> < 5 × 10<sup>-8</sup>) was validated in both populations. The investigation of Tibetan <i>EPAS1</i> revealed the rs1374749 locus, along with linked loci, as a potential prevalence factor for HAPC. The GGTAC haplotype containing this locus emerged as a Protect haplotype for HAPC (<i>p</i> = 2.461 × 10<sup>-12</sup>, OR = 0.344). Enrichment analysis revealed that Tibetans exhibited susceptibility in oxygen-sensing pathways, such as EPAS1, associated with phenotypes like hemoglobin and platelets. In contrast, Han Chinese showed significant sensitivity in cell differentiation and angiogenesis, closely linked to hemoglobin, hematocrit, and platelets.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s43657-024-00180-y.</p>","PeriodicalId":74435,"journal":{"name":"Phenomics (Cham, Switzerland)","volume":"5 2","pages":"169-182"},"PeriodicalIF":3.7,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12209065/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144556111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Precision Dietary Intervention: Gut Microbiome and Meta-metabolome as Functional Readouts. 精确饮食干预:肠道微生物组和元代谢组作为功能读数。
IF 3.7 Q2 GENETICS & HEREDITY Pub Date : 2025-02-14 eCollection Date: 2025-02-01 DOI: 10.1007/s43657-024-00193-7
Jing Luo, Yulan Wang

Gut microbiome, the group of commensals residing within the intestinal tract, is closely associated with dietary patterns by interacting with food components. The gut microbiome is modifiable by the diet, and in turn, it utilizes the undigested food components as substrates and generates a group of small molecule-metabolites that addressed as "meta-metabolome" in this review. Profiling and mapping of meta-metabolome could yield insightful information at higher resolution and serve as functional readouts for precision nutrition and formation of personalized dietary strategies. For assessing the meta-metabolome, sample preparation is important, and it should aim for retrieval of gut microbial metabolites as intact as possible. The meta-metabolome can be investigated via untargeted and targeted meta-metabolomics with analytical platforms such as nuclear magnetic resonance spectroscopy and mass spectrometry. Employing flux analysis with meta-metabolomics using available database could further elucidate metabolic pathways that lead to biomarker discovery. In conclusion, integration of gut microbiome and meta-metabolomics is a promising supplementary approach to tailor precision dietary intervention. In this review, relationships among diet, gut microbiome, and meta-metabolome are elucidated, with an emphasis on recent advances in alternative analysis techniques proposed for nutritional research. We hope that this review will provide information for establishing pipelines complementary to traditional approaches for achieving precision dietary intervention.

肠道微生物群是一组生活在肠道内的共生体,通过与食物成分的相互作用与饮食模式密切相关。肠道微生物组可以被饮食改变,反过来,它利用未消化的食物成分作为底物,产生一组小分子代谢物,在本综述中被称为“元代谢组”。元代谢组的分析和制图可以获得更高分辨率的深刻信息,并作为精确营养和个性化饮食策略形成的功能读数。为了评估meta代谢组,样品制备是重要的,它应该以尽可能完整地检索肠道微生物代谢物为目标。meta代谢组可以通过非靶向和靶向meta代谢组学与核磁共振波谱和质谱等分析平台进行研究。利用现有数据库进行meta代谢组学通量分析可以进一步阐明导致生物标志物发现的代谢途径。综上所述,肠道微生物组和元代谢组学的整合是一种有希望的补充方法,可以定制精确的饮食干预。本文综述了饮食、肠道微生物组和元代谢组之间的关系,重点介绍了营养研究中替代分析技术的最新进展。我们希望这篇综述将为建立与传统方法互补的管道以实现精确的饮食干预提供信息。
{"title":"Precision Dietary Intervention: Gut Microbiome and Meta-metabolome as Functional Readouts.","authors":"Jing Luo, Yulan Wang","doi":"10.1007/s43657-024-00193-7","DOIUrl":"10.1007/s43657-024-00193-7","url":null,"abstract":"<p><p>Gut microbiome, the group of commensals residing within the intestinal tract, is closely associated with dietary patterns by interacting with food components. The gut microbiome is modifiable by the diet, and in turn, it utilizes the undigested food components as substrates and generates a group of small molecule-metabolites that addressed as \"meta-metabolome\" in this review. Profiling and mapping of meta-metabolome could yield insightful information at higher resolution and serve as functional readouts for precision nutrition and formation of personalized dietary strategies. For assessing the meta-metabolome, sample preparation is important, and it should aim for retrieval of gut microbial metabolites as intact as possible. The meta-metabolome can be investigated via untargeted and targeted meta-metabolomics with analytical platforms such as nuclear magnetic resonance spectroscopy and mass spectrometry. Employing flux analysis with meta-metabolomics using available database could further elucidate metabolic pathways that lead to biomarker discovery. In conclusion, integration of gut microbiome and meta-metabolomics is a promising supplementary approach to tailor precision dietary intervention. In this review, relationships among diet, gut microbiome, and meta-metabolome are elucidated, with an emphasis on recent advances in alternative analysis techniques proposed for nutritional research. We hope that this review will provide information for establishing pipelines complementary to traditional approaches for achieving precision dietary intervention.</p>","PeriodicalId":74435,"journal":{"name":"Phenomics (Cham, Switzerland)","volume":"5 1","pages":"23-50"},"PeriodicalIF":3.7,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12040796/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144051787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of a Novel Pyroptosis-Related lncRNAs Prognosis Model and Subtypes in Ovarian Cancer. 一种新的卵巢癌热相关lncrna预后模型和亚型的鉴定。
IF 6.2 Q2 GENETICS & HEREDITY Pub Date : 2025-02-10 eCollection Date: 2025-06-01 DOI: 10.1007/s43657-024-00173-x
Xiao-Feng Xie, Xiao-Qian Hu, Deng-Xiang Liu, Wei Wang, Tian Hua

Ovarian cancer (OC), a predominant gynecological malignancy, has consistently showcased grim prognostic outcomes. This investigation delves into the emerging field of pyroptosis and the intricacies of long non-coding RNAs (lncRNAs), specifically the lesser-studied pyroptosis-related lncRNAs (PRlncRNAs), and their roles in OC prognosis. By harnessing transcriptome, and clinic data from the genotype-tissue expression (GTEx) and the cancer genome Atlas (TCGA), we formulated a unique PRlncRNAs risk model consisting of five prognostic lncRNAs by Cox regression and least absolute shrinkage and selection operator (LASSO) regression. Next, the Kaplan-Meier analysis, receiver operating characteristic (ROC) curve, nomogram, and calibration were implemented to verify and evaluate the model. The model also showed general applicability in pan-cancer analysis. Remarkably, our model, upon rigorous validation, outperformed 16 pre-existing counterparts, offering a promising avenue for prognosis prediction. The risk score was used to classify patients into high and low-risk subgroups. The low-risk group showed improved overall survival (OS) and progression-free survival (PFS). The risk score was proved to be an independent prognosis factor. The low-risk group patients also exhibited a higher immune infiltration score and homologous recombination deficiency (HRD) score. Moreover, consensus clustering analysis was utilized to categorize OC patients into three distinct groups, predicated on the expression of the five prognostic lncRNAs. Patients within the third cluster exhibited noteworthy traits, encompassing elevated survival, heightened immune checkpoint expression, and the HRD score. Finally, the expressions of five PRlncRNAs were validated by quantitative real-time PCR (qRT-PCR) in OC cell lines and tissues. In conclusion, the risk model based on the five PRlncRNAs might function as prognostic biomarkers to predict the immune and target drug treatment in OC.

Supplementary information: The online version contains supplementary material available at 10.1007/s43657-024-00173-x.

卵巢癌(OC),一个主要的妇科恶性肿瘤,一直显示出严峻的预后结果。本研究深入探讨了新兴的焦亡领域和长链非编码rna (lncRNAs)的复杂性,特别是研究较少的焦亡相关lncRNAs (PRlncRNAs),以及它们在OC预后中的作用。通过利用来自基因型组织表达(GTEx)和癌症基因组图谱(TCGA)的转录组和临床数据,我们通过Cox回归和最小绝对收缩和选择算子(LASSO)回归建立了一个独特的PRlncRNAs风险模型,该模型由5个预后lncRNAs组成。然后,应用Kaplan-Meier分析、受试者工作特征(ROC)曲线、nomogram和calibration对模型进行验证和评价。该模型在泛癌症分析中也具有普遍适用性。值得注意的是,我们的模型经过严格的验证,优于16个已有的同行,为预后预测提供了一个有希望的途径。使用风险评分将患者分为高风险和低风险亚组。低危组总生存期(OS)和无进展生存期(PFS)均有改善。风险评分是独立的预后因素。低危组患者免疫浸润评分和同源重组缺陷(HRD)评分也较高。此外,根据五种预后lncrna的表达,采用共识聚类分析将OC患者分为三个不同的组。第三组患者表现出值得注意的特征,包括生存率升高、免疫检查点表达升高和HRD评分。最后,通过实时荧光定量PCR (qRT-PCR)验证5个PRlncRNAs在OC细胞系和组织中的表达。综上所述,基于5种prlncrna的风险模型可能作为预测OC免疫和靶向药物治疗的预后生物标志物。补充信息:在线版本包含补充资料,下载地址为10.1007/s43657-024-00173-x。
{"title":"Identification of a Novel Pyroptosis-Related lncRNAs Prognosis Model and Subtypes in Ovarian Cancer.","authors":"Xiao-Feng Xie, Xiao-Qian Hu, Deng-Xiang Liu, Wei Wang, Tian Hua","doi":"10.1007/s43657-024-00173-x","DOIUrl":"10.1007/s43657-024-00173-x","url":null,"abstract":"<p><p>Ovarian cancer (OC), a predominant gynecological malignancy, has consistently showcased grim prognostic outcomes. This investigation delves into the emerging field of pyroptosis and the intricacies of long non-coding RNAs (lncRNAs), specifically the lesser-studied pyroptosis-related lncRNAs (PRlncRNAs), and their roles in OC prognosis. By harnessing transcriptome, and clinic data from the genotype-tissue expression (GTEx) and the cancer genome Atlas (TCGA), we formulated a unique PRlncRNAs risk model consisting of five prognostic lncRNAs by Cox regression and least absolute shrinkage and selection operator (LASSO) regression. Next, the Kaplan-Meier analysis, receiver operating characteristic (ROC) curve, nomogram, and calibration were implemented to verify and evaluate the model. The model also showed general applicability in pan-cancer analysis. Remarkably, our model, upon rigorous validation, outperformed 16 pre-existing counterparts, offering a promising avenue for prognosis prediction. The risk score was used to classify patients into high and low-risk subgroups. The low-risk group showed improved overall survival (OS) and progression-free survival (PFS). The risk score was proved to be an independent prognosis factor. The low-risk group patients also exhibited a higher immune infiltration score and homologous recombination deficiency (HRD) score. Moreover, consensus clustering analysis was utilized to categorize OC patients into three distinct groups, predicated on the expression of the five prognostic lncRNAs. Patients within the third cluster exhibited noteworthy traits, encompassing elevated survival, heightened immune checkpoint expression, and the HRD score. Finally, the expressions of five PRlncRNAs were validated by quantitative real-time PCR (qRT-PCR) in OC cell lines and tissues. In conclusion, the risk model based on the five PRlncRNAs might function as prognostic biomarkers to predict the immune and target drug treatment in OC.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s43657-024-00173-x.</p>","PeriodicalId":74435,"journal":{"name":"Phenomics (Cham, Switzerland)","volume":"5 3","pages":"284-300"},"PeriodicalIF":6.2,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12390916/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144981648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impacts of Behavioral Compliance on Weight-Loss and Metabolic Profile in a Smartphone App-Based Lifestyle Intervention or Plus Dietitian Supporting: A Randomized and Controlled Trial Among Chinese. 基于智能手机应用程序的生活方式干预或加上营养师支持的行为依从性对减肥和代谢特征的影响:一项随机对照试验
IF 3.7 Q2 GENETICS & HEREDITY Pub Date : 2025-01-30 eCollection Date: 2025-04-01 DOI: 10.1007/s43657-024-00162-0
Xue Li, Ling Lu, Liang Sun, Yunxia Xie, Kang Huang, Changzheng Yuan, Liying Chen, Xu Lin

Mobile health technologies provided innovative solutions for lifestyle interventions and offered reliable methods to evaluate behavioral phenotypes during such interventions. To systematically quantify the impacts of behavioral compliance on weight-loss and metabolic profiles during lifestyle intervention, a total of 395 Chinese adults with overweight/obesity (BMI ≥ 24 kg/m2) or central obesity (waistline ≥ 90 cm for men or ≥ 80 cm for women) were randomly assigned to a smartphone app-based arm (SAA, n = 197) or smartphone app plus dietitian arm (SADA, n = 198) for 6 months. Compliance scores (0-5) were determined based on fulfilling five behavioral tasks: completing online courses, wearing a smart band, and recording weight, food intake, and blood pressure. SADA had greater weight-loss (- 4.94% vs. - 2.28%, p < 0.001) and lower triglyceride, but higher HDL-C levels (both p < 0.05) than SAA after six months. Between-group weight-loss differences were attenuated at compliance scores ≥ 3 (SADA: - 6.30% vs. SAA: - 4.79%, p = 0.07). Mediation analysis suggested that compliance scores explained approximately 30% of the additional weight loss in the SADA (p < 0.001), and self-weighing was the primary mediator (p < 0.05). Higher educational levels, greater initial weight loss, self-perceived simplicity, and satisfaction with the program were potential determinants of intervention compliance. Overall, the superior weight loss and metabolic improvements in the SADA group could be mediated by behavioral compliance, which was possibly influenced by some demographic and intervention response features. Our findings highlighted the roles of behavioral phenotypes and adherence in app-based lifestyle interventions, and added evidence for the future development of more precise strategies in long-term weight management.

Supplementary information: The online version contains supplementary material available at 10.1007/s43657-024-00162-0.

移动医疗技术为生活方式干预提供了创新的解决方案,并提供了评估此类干预期间行为表型的可靠方法。为了系统地量化行为依从性对生活方式干预期间减肥和代谢特征的影响,共有395名超重/肥胖(BMI≥24 kg/m2)或中心性肥胖(男性腰围≥90 cm或女性腰围≥80 cm)的中国成年人被随机分配到基于智能手机应用程序的组(SAA, n = 197)或智能手机应用程序加营养师组(SADA, n = 198),为期6个月。依从性分数(0-5分)是根据完成在线课程、佩戴智能手环、记录体重、食物摄入量和血压等5项行为任务来确定的。萨达曾大减肥(- 4.94%比2.28%,p p p = 0.07)。调解分析表明,依从性评分解释了SADA中大约30%的额外体重减轻(p p)补充信息:在线版本包含补充材料,可在10.1007/s43657-024-00162-0获得。
{"title":"Impacts of Behavioral Compliance on Weight-Loss and Metabolic Profile in a Smartphone App-Based Lifestyle Intervention or Plus Dietitian Supporting: A Randomized and Controlled Trial Among Chinese.","authors":"Xue Li, Ling Lu, Liang Sun, Yunxia Xie, Kang Huang, Changzheng Yuan, Liying Chen, Xu Lin","doi":"10.1007/s43657-024-00162-0","DOIUrl":"10.1007/s43657-024-00162-0","url":null,"abstract":"<p><p>Mobile health technologies provided innovative solutions for lifestyle interventions and offered reliable methods to evaluate behavioral phenotypes during such interventions. To systematically quantify the impacts of behavioral compliance on weight-loss and metabolic profiles during lifestyle intervention, a total of 395 Chinese adults with overweight/obesity (BMI ≥ 24 kg/m<sup>2</sup>) or central obesity (waistline ≥ 90 cm for men or ≥ 80 cm for women) were randomly assigned to a smartphone app-based arm (SAA, n = 197) or smartphone app plus dietitian arm (SADA, n = 198) for 6 months. Compliance scores (0-5) were determined based on fulfilling five behavioral tasks: completing online courses, wearing a smart band, and recording weight, food intake, and blood pressure. SADA had greater weight-loss (- 4.94% vs. - 2.28%, <i>p</i> < 0.001) and lower triglyceride, but higher HDL-C levels (both <i>p</i> < 0.05) than SAA after six months. Between-group weight-loss differences were attenuated at compliance scores ≥ 3 (SADA: - 6.30% vs. SAA: - 4.79%, <i>p</i> = 0.07). Mediation analysis suggested that compliance scores explained approximately 30% of the additional weight loss in the SADA (<i>p</i> < 0.001), and self-weighing was the primary mediator (<i>p</i> < 0.05). Higher educational levels, greater initial weight loss, self-perceived simplicity, and satisfaction with the program were potential determinants of intervention compliance. Overall, the superior weight loss and metabolic improvements in the SADA group could be mediated by behavioral compliance, which was possibly influenced by some demographic and intervention response features. Our findings highlighted the roles of behavioral phenotypes and adherence in app-based lifestyle interventions, and added evidence for the future development of more precise strategies in long-term weight management.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s43657-024-00162-0.</p>","PeriodicalId":74435,"journal":{"name":"Phenomics (Cham, Switzerland)","volume":"5 2","pages":"154-168"},"PeriodicalIF":3.7,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12209060/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144556112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cell Function Experiments and Bioinformatics Analysis Jointly Revealed the Antineoplastic Effect of Lumican on Hepatocellular Carcinoma. 细胞功能实验和生物信息学分析共同揭示了Lumican对肝细胞癌的抗肿瘤作用。
IF 6.2 Q2 GENETICS & HEREDITY Pub Date : 2025-01-27 eCollection Date: 2025-06-01 DOI: 10.1007/s43657-024-00182-w
Xiaoyu Zhou, Zixuan Xing, Ruijun Dong, Xi Zhang, Xuefeng Liang, Zhengyang Lu, Ganghua Yang

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and immune checkpoint inhibitor (ICI)-based therapies are now an integral part of systemic treatment. In this study, we identify potential biomarker for HCC and further investigate its functional significance using both bioinformatic and experimental methods. Differential analysis and weighted gene co-expression network analysis (WGCNA) were conducted, identifying lumican (LUM) as the target gene. Our results showed a significant downregulation of LUM in HCC. LUM expression was also associated with the progression-free interval and the infiltration of B cells, neutrophils, and myeloid dendritic cells. Enrichment analysis highlighted the involvement of LUM in focal adhesion and the extracellular matrix. In addition, overexpression of LUM suppressed proliferation, migration and invasion in hepatoma cell lines while promoting cell apoptosis. Our results demonstrate the importance of LUM in HCC development and may help to elucidate the underlying mechanisms and biological processes influenced by LUM.

Supplementary information: The online version contains supplementary material available at 10.1007/s43657-024-00182-w.

肝细胞癌(HCC)是世界范围内最常见的癌症之一,基于免疫检查点抑制剂(ICI)的治疗现在是全身治疗的一个组成部分。在本研究中,我们通过生物信息学和实验方法,确定潜在的HCC生物标志物,并进一步研究其功能意义。通过差异分析和加权基因共表达网络分析(WGCNA),确定lumican (LUM)为靶基因。我们的研究结果显示,在HCC中,LUM显著下调。LUM的表达也与无进展间隔和B细胞、中性粒细胞和骨髓树突状细胞的浸润有关。富集分析强调了LUM参与局灶黏附和细胞外基质。此外,过表达LUM可抑制肝癌细胞系的增殖、迁移和侵袭,促进细胞凋亡。我们的研究结果证明了LUM在HCC发展中的重要性,并可能有助于阐明受LUM影响的潜在机制和生物学过程。补充信息:在线版本包含补充资料,下载地址:10.1007/s43657-024-00182-w。
{"title":"Cell Function Experiments and Bioinformatics Analysis Jointly Revealed the Antineoplastic Effect of Lumican on Hepatocellular Carcinoma.","authors":"Xiaoyu Zhou, Zixuan Xing, Ruijun Dong, Xi Zhang, Xuefeng Liang, Zhengyang Lu, Ganghua Yang","doi":"10.1007/s43657-024-00182-w","DOIUrl":"10.1007/s43657-024-00182-w","url":null,"abstract":"<p><p>Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and immune checkpoint inhibitor (ICI)-based therapies are now an integral part of systemic treatment. In this study, we identify potential biomarker for HCC and further investigate its functional significance using both bioinformatic and experimental methods. Differential analysis and weighted gene co-expression network analysis (WGCNA) were conducted, identifying <i>lumican</i> (<i>LUM</i>) as the target gene. Our results showed a significant downregulation of <i>LUM</i> in HCC. <i>LUM</i> expression was also associated with the progression-free interval and the infiltration of B cells, neutrophils, and myeloid dendritic cells. Enrichment analysis highlighted the involvement of <i>LUM</i> in focal adhesion and the extracellular matrix. In addition, overexpression of <i>LUM</i> suppressed proliferation, migration and invasion in hepatoma cell lines while promoting cell apoptosis. Our results demonstrate the importance of <i>LUM</i> in HCC development and may help to elucidate the underlying mechanisms and biological processes influenced by <i>LUM</i>.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s43657-024-00182-w.</p>","PeriodicalId":74435,"journal":{"name":"Phenomics (Cham, Switzerland)","volume":"5 3","pages":"252-269"},"PeriodicalIF":6.2,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12391580/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144981698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics of the Corneal Endothelium in Elderly Adults with High Myopia. 老年高度近视患者角膜内皮细胞的特征。
IF 6.2 Q2 GENETICS & HEREDITY Pub Date : 2025-01-27 eCollection Date: 2024-12-01 DOI: 10.1007/s43657-024-00186-6
Yinglei Zhang, Shaohua Zhang, Keke Zhang, Yi Lu, Xiangjia Zhu

This cross-sectional study aimed to investigate the corneal endothelial characteristics in elderly individuals with high myopia. We assessed corneal endothelial characteristics in 1065 eyes of 1065 elderly patients (549 highly myopic and 516 control eyes) using non-contact specular microscopy. Confirmation of suspected Fuchs endothelial corneal dystrophy (FECD) was performed with slit-lamp and confocal microscopy. Highly myopic eyes exhibited significantly greater central endothelial cell density (ECD) and coefficient of variation (CV) (p = 0.001 and p = 0.002, respectively), and lower average cell area (AVG) and percent of hexagonality (HEX) (p = 0.014 and p < 0.001, respectively) compared to control eyes. After adjusting for age and gender, axial length (AL) was positively correlated with ECD and CV (r = 0.130, p < 0.001 and r = 0.113, p < 0.001, respectively), and was negatively correlated with AVG and HEX (r = - 0.105, p = 0.001 and r = - 0.204, p < 0.001, respectively). FECD prevalence was 4.92% in highly myopic eyes and 3.29% in controls, with more advanced cases in highly myopic eyes (p = 0.036). In conclusion, longer AL was associated with increased corneal ECD, and greater endothelial pleomorphism and polymegethism in elderly patients. Highly myopic eyes appeared to have higher prevalence and severity of FECD. The study was registered on www.clinicaltrials.gov on February 26, 2017, with the registration number NCT03062085.

本横断面研究旨在探讨老年高度近视患者角膜内皮的特征。我们使用非接触式镜面显微镜对1065例老年患者(549只高度近视眼和516只对照眼)的1065只眼的角膜内皮特征进行了评估。用裂隙灯和共聚焦显微镜确认疑似Fuchs内皮性角膜营养不良(FECD)。高度近视眼的中心内皮细胞密度(ECD)和变异系数(CV)显著增加(p = 0.001和p = 0.002),平均细胞面积(AVG)和六边形百分比(HEX)显著降低(p = 0.014和p = 0.130, p = 0.113, p = - 0.105, p = 0.001和r = - 0.204, p = 0.036)。综上所述,较长的AL与老年患者角膜ECD增加以及内皮多形性和多聚性增加有关。高度近视眼有较高的FECD患病率和严重程度。该研究于2017年2月26日在www.clinicaltrials.gov上注册,注册号为NCT03062085。
{"title":"Characteristics of the Corneal Endothelium in Elderly Adults with High Myopia.","authors":"Yinglei Zhang, Shaohua Zhang, Keke Zhang, Yi Lu, Xiangjia Zhu","doi":"10.1007/s43657-024-00186-6","DOIUrl":"10.1007/s43657-024-00186-6","url":null,"abstract":"<p><p>This cross-sectional study aimed to investigate the corneal endothelial characteristics in elderly individuals with high myopia. We assessed corneal endothelial characteristics in 1065 eyes of 1065 elderly patients (549 highly myopic and 516 control eyes) using non-contact specular microscopy. Confirmation of suspected Fuchs endothelial corneal dystrophy (FECD) was performed with slit-lamp and confocal microscopy. Highly myopic eyes exhibited significantly greater central endothelial cell density (ECD) and coefficient of variation (CV) (<i>p</i> = 0.001 and <i>p</i> = 0.002, respectively), and lower average cell area (AVG) and percent of hexagonality (HEX) (<i>p</i> = 0.014 and <i>p</i> < 0.001, respectively) compared to control eyes. After adjusting for age and gender, axial length (AL) was positively correlated with ECD and CV (<i>r</i> = 0.130, <i>p</i> < 0.001 and <i>r</i> = 0.113, <i>p</i> < 0.001, respectively), and was negatively correlated with AVG and HEX (<i>r</i> = - 0.105, <i>p</i> = 0.001 and <i>r</i> = - 0.204, <i>p</i> < 0.001, respectively). FECD prevalence was 4.92% in highly myopic eyes and 3.29% in controls, with more advanced cases in highly myopic eyes (<i>p</i> = 0.036). In conclusion, longer AL was associated with increased corneal ECD, and greater endothelial pleomorphism and polymegethism in elderly patients. Highly myopic eyes appeared to have higher prevalence and severity of FECD. The study was registered on www.clinicaltrials.gov on February 26, 2017, with the registration number NCT03062085.</p>","PeriodicalId":74435,"journal":{"name":"Phenomics (Cham, Switzerland)","volume":"4 6","pages":"562-569"},"PeriodicalIF":6.2,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11889312/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143588564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Amyotrophic Lateral Sclerosis and Risk of Common Cancer: Mendelian Randomization Interrogation of Causality and Mediation. 肌萎缩性侧索硬化症与常见癌症的风险:因果关系和中介的孟德尔随机化质疑。
IF 6.2 Q2 GENETICS & HEREDITY Pub Date : 2025-01-26 eCollection Date: 2025-06-01 DOI: 10.1007/s43657-024-00159-9
Xiaoxue Tan, Gaifen Liu, Xiangnan Li, Fan Zhong, Zhixi Su, Haijian Wang

Compared with the well-documented inverse comorbidity of common neurodegenerative diseases with some types of cancer, the association of amyotrophic lateral sclerosis (ALS) with cancer was obscure. This Mendelian randomization (MR) analysis was aimed to appraise the causal relationship of ALS with cancer. Leveraging summary statistics of genome-wide association study (GWAS) for ALS, overall-cancer and nine types of site-specific common solid cancer including colorectal cancer (CRC) in populations of European (discovery and replication) and East Asian ancestry, we investigated the causal association of ALS with cancer using inverse-variance weighted (IVW) method and complementary sensitivity analyses. We performed MR-based mediation analysis to assess possible role of serum lipid traits such as hyperlipidemia, one shared risk factor of ALS and CRC, in their causal association. We found that genetically-predicted ALS was not associated with overall-cancer and other tested types of cancer, but was causally associated with reduced risk of CRC [odds ratio (OR) 0.84; 95% confidence interval (95% CI) 0.74-0.96; p = 0.011, OR 0.32; 95% CI 0.15-0.69; p = 0.004, in datasets of European (discovery) and East Asian ancestry respectively]. We observed absences of directional pleiotropy (MR Egger, intercept = -0.02 and -0.02, p = 0.49 and 0.60), instrumental outlier (MR-PRESSO, p = 0.95 and 0.84) or heterogeneity (Cochran Q, p = 0.95 and 0.82). Null reverse causality of CRC with ALS was found in either datasets. However, we found no evidence of the inverse association of ALS with CRC in either the replication (OR 0.99; 95% CI 0.93-1.06) or the combined European datasets (OR 0.92; 95% CI 0.79-1.09). Mediation analysis in European datasets suggested that hyperlipidemia may affect the risk of CRC via ALS in an indirect manner, with the measured mediation effect of hyperlipidemia on CRC being -0.02 (95% CI -0.04 to -0.002, p = 0.03). Our two-sample MR study in trans-ethnic populations uncovered that genetically proxied ALS may be causally associated with reduced risk of CRC, providing new insight into the inverse comorbidity and etiological causality of neurodegenerative disease and cancer.

Supplementary information: The online version contains supplementary material available at 10.1007/s43657-024-00159-9.

与文献记载的常见神经退行性疾病与某些类型癌症的反向共病相比,肌萎缩侧索硬化症(ALS)与癌症的关系尚不清楚。这项孟德尔随机化(MR)分析旨在评估ALS与癌症的因果关系。利用全基因组关联研究(GWAS)对欧洲(发现和复制)和东亚血统人群中ALS、整体癌症和9种位点特异性常见实体癌症(包括结直肠癌)的汇总统计数据,我们使用反方差加权(IVW)方法和互补敏感性分析来研究ALS与癌症的因果关系。我们进行了基于磁共振的中介分析,以评估血脂特征(如高脂血症)在其因果关系中的可能作用,高脂血症是ALS和CRC的一个共同危险因素。我们发现,基因预测的ALS与总体癌症和其他测试类型的癌症无关,但与CRC风险降低有因果关系[比值比(OR) 0.84;95%置信区间(95% CI) 0.74-0.96;p = 0.011, OR 0.32;95% ci 0.15-0.69;p = 0.004,分别在欧洲(发现)和东亚血统的数据集中]。我们观察到不存在方向性多效性(MR Egger,截距= -0.02和-0.02,p = 0.49和0.60)、工具异常值(MR- presso, p = 0.95和0.84)或异质性(Cochran Q, p = 0.95和0.82)。在两组数据中均未发现结直肠癌与ALS的反向因果关系。然而,我们在复制(OR 0.99; 95% CI 0.93-1.06)或欧洲联合数据集(OR 0.92; 95% CI 0.79-1.09)中均未发现ALS与CRC负相关的证据。欧洲数据集的中介分析表明,高脂血症可能以间接方式影响经ALS发生CRC的风险,测量到的高脂血症对CRC的中介效应为-0.02 (95% CI -0.04 ~ -0.002, p = 0.03)。我们在跨种族人群中进行的两样本MR研究发现,遗传代理的ALS可能与结直肠癌风险降低有因果关系,为神经退行性疾病和癌症的逆共病和病因因果关系提供了新的见解。补充信息:在线版本包含补充资料,下载地址:10.1007/s43657-024-00159-9。
{"title":"Amyotrophic Lateral Sclerosis and Risk of Common Cancer: Mendelian Randomization Interrogation of Causality and Mediation.","authors":"Xiaoxue Tan, Gaifen Liu, Xiangnan Li, Fan Zhong, Zhixi Su, Haijian Wang","doi":"10.1007/s43657-024-00159-9","DOIUrl":"10.1007/s43657-024-00159-9","url":null,"abstract":"<p><p>Compared with the well-documented inverse comorbidity of common neurodegenerative diseases with some types of cancer, the association of amyotrophic lateral sclerosis (ALS) with cancer was obscure. This Mendelian randomization (MR) analysis was aimed to appraise the causal relationship of ALS with cancer. Leveraging summary statistics of genome-wide association study (GWAS) for ALS, overall-cancer and nine types of site-specific common solid cancer including colorectal cancer (CRC) in populations of European (discovery and replication) and East Asian ancestry, we investigated the causal association of ALS with cancer using inverse-variance weighted (IVW) method and complementary sensitivity analyses. We performed MR-based mediation analysis to assess possible role of serum lipid traits such as hyperlipidemia, one shared risk factor of ALS and CRC, in their causal association. We found that genetically-predicted ALS was not associated with overall-cancer and other tested types of cancer, but was causally associated with reduced risk of CRC [odds ratio (OR) 0.84; 95% confidence interval (95% CI) 0.74-0.96; <i>p</i> = 0.011, OR 0.32; 95% CI 0.15-0.69; <i>p</i> = 0.004, in datasets of European (discovery) and East Asian ancestry respectively]. We observed absences of directional pleiotropy (MR Egger, intercept = -0.02 and -0.02, <i>p</i> = 0.49 and 0.60), instrumental outlier (MR-PRESSO, <i>p</i> = 0.95 and 0.84) or heterogeneity (Cochran <i>Q</i>, <i>p</i> = 0.95 and 0.82). Null reverse causality of CRC with ALS was found in either datasets. However, we found no evidence of the inverse association of ALS with CRC in either the replication (OR 0.99; 95% CI 0.93-1.06) or the combined European datasets (OR 0.92; 95% CI 0.79-1.09). Mediation analysis in European datasets suggested that hyperlipidemia may affect the risk of CRC via ALS in an indirect manner, with the measured mediation effect of hyperlipidemia on CRC being -0.02 (95% CI -0.04 to -0.002, <i>p</i> = 0.03). Our two-sample MR study in <i>trans</i>-ethnic populations uncovered that genetically proxied ALS may be causally associated with reduced risk of CRC, providing new insight into the inverse comorbidity and etiological causality of neurodegenerative disease and cancer.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s43657-024-00159-9.</p>","PeriodicalId":74435,"journal":{"name":"Phenomics (Cham, Switzerland)","volume":"5 3","pages":"270-283"},"PeriodicalIF":6.2,"publicationDate":"2025-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12390901/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144981667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Newly Identified Genes Linked to Tetralogy of Fallot. 新发现的法洛四联症相关基因。
IF 6.2 Q2 GENETICS & HEREDITY Pub Date : 2025-01-21 eCollection Date: 2024-12-01 DOI: 10.1007/s43657-024-00203-8
Ying Liu, Weinian Shou
{"title":"Newly Identified Genes Linked to Tetralogy of Fallot.","authors":"Ying Liu, Weinian Shou","doi":"10.1007/s43657-024-00203-8","DOIUrl":"10.1007/s43657-024-00203-8","url":null,"abstract":"","PeriodicalId":74435,"journal":{"name":"Phenomics (Cham, Switzerland)","volume":"4 6","pages":"633-634"},"PeriodicalIF":6.2,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11889324/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143588612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MST1R Gene Variants Predispose Individuals to Tetralogy of Fallot. MST1R基因变异使个体易患法洛四联症。
IF 3.7 Q2 GENETICS & HEREDITY Pub Date : 2025-01-21 eCollection Date: 2024-12-01 DOI: 10.1007/s43657-024-00175-9
Zhiyu Feng, Xianghui Huang, Yuan Gao, Han Gao, Weilan Na, Chaozhong Tan, Shaojie Min, Yuquan Lu, Quannan Zhuang, Siyi Lin, Xiaojing Ma, Weicheng Chen, Weili Yan, Wei Sheng, Guoying Huang

Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart malformation. While a few susceptibility genes for TOF have been identified, research on the genetic basis of TOF is limited. The Macrophage stimulating 1 receptor (MST1R) gene encodes the macrophage-stimulating protein receptor with tyrosine phosphatase activity that is involved in immune defense. In this study, we performed whole-exome sequencing (WES) on 10 TOF families and 50 sporadic TOF patients and identified a recessive homozygous missense mutation in MST1R, c.T2009G: p.V670G, in two offspring with TOF in a single family. Targeted sequencing of the MST1R gene showed enrichment for rare variants in 417 TOF patients compared with East Asians in Genome Aggregation Database Version 2 (gnomADv2_EAS). MST1R-deficient human induced pluripotent stem cells (hiPSCs) maintained normal pluripotency but differentiated into non-functional cardiomyocytes (CMs). Taken together, our findings indicate that MST1R may play a critical role in cardiac differentiation and genetic variations in MST1R may be associated with the pathogenesis of TOF.

Supplementary information: The online version contains supplementary material available at 10.1007/s43657-024-00175-9.

法洛四联症(TOF)是最常见的青紫型先天性心脏畸形。虽然已经确定了一些TOF的易感基因,但对TOF遗传基础的研究还很有限。巨噬细胞刺激1受体(MST1R)基因编码具有酪氨酸磷酸酶活性的巨噬细胞刺激蛋白受体,参与免疫防御。在本研究中,我们对10个TOF家族和50例散发性TOF患者进行了全外显子组测序(WES),在同一个家族的两个TOF后代中发现了MST1R基因c.T2009G: p.V670G的隐性纯合错义突变。基因组聚集数据库2 (gnomADv2_EAS)的MST1R基因靶向测序显示,与东亚人相比,417例TOF患者的罕见变异丰富。缺乏mst1r的人诱导多能干细胞(hiPSCs)维持正常的多能性,但分化为无功能心肌细胞(CMs)。综上所述,我们的研究结果表明,MST1R可能在心脏分化中发挥关键作用,MST1R的遗传变异可能与TOF的发病机制有关。补充资料:在线版本包含补充资料,下载地址:10.1007/s43657-024-00175-9。
{"title":"<i>MST1R</i> Gene Variants Predispose Individuals to Tetralogy of Fallot.","authors":"Zhiyu Feng, Xianghui Huang, Yuan Gao, Han Gao, Weilan Na, Chaozhong Tan, Shaojie Min, Yuquan Lu, Quannan Zhuang, Siyi Lin, Xiaojing Ma, Weicheng Chen, Weili Yan, Wei Sheng, Guoying Huang","doi":"10.1007/s43657-024-00175-9","DOIUrl":"10.1007/s43657-024-00175-9","url":null,"abstract":"<p><p>Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart malformation. While a few susceptibility genes for TOF have been identified, research on the genetic basis of TOF is limited. The <i>Macrophage stimulating 1 receptor</i> (<i>MST1R</i>) gene encodes the macrophage-stimulating protein receptor with tyrosine phosphatase activity that is involved in immune defense. In this study, we performed whole-exome sequencing (WES) on 10 TOF families and 50 sporadic TOF patients and identified a recessive homozygous missense mutation in <i>MST1R</i>, c.T2009G: p.V670G, in two offspring with TOF in a single family. Targeted sequencing of the <i>MST1R</i> gene showed enrichment for rare variants in 417 TOF patients compared with East Asians in Genome Aggregation Database Version 2 (gnomADv2_EAS). <i>MST1R</i>-deficient human induced pluripotent stem cells (hiPSCs) maintained normal pluripotency but differentiated into non-functional cardiomyocytes (CMs). Taken together, our findings indicate that <i>MST1R</i> may play a critical role in cardiac differentiation and genetic variations in <i>MST1R</i> may be associated with the pathogenesis of TOF.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s43657-024-00175-9.</p>","PeriodicalId":74435,"journal":{"name":"Phenomics (Cham, Switzerland)","volume":"4 6","pages":"548-561"},"PeriodicalIF":3.7,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11889330/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143588502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Phenomics (Cham, Switzerland)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1